Polyhexamethylene biguanide and calcineurin inhibitors as novel antifungal treatments for Aspergillus keratitis

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 10, 2011, Pages 7309-7315

  Rebong, Rachelle A ^a   Santaella, Ricardo M ^a   Goldhagen, Brian E ^a   Majka, Christopher P ^a   Perfect, John R ^a   Steinbach, William J ^a   Afshari, Natalie A ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; CYCLOSPORIN A; POLY (HEXAMETHYLENEBIGUANIDE); TACROLIMUS; UNCLASSIFIED DRUG; VORICONAZOLE; BIGUANIDE DERIVATIVE; CALCINEURIN; CYCLOSPORIN; DISINFECTANT AGENT; IMMUNOSUPPRESSIVE AGENT; POLY(HEXAMETHYLENEBIGUANIDE); PYRIMIDINE DERIVATIVE; TRIAZOLE DERIVATIVE;

ALOPECIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIFUNGAL ACTIVITY; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; ASPERGILLUS; CONTROLLED STUDY; DISEASE SEVERITY; FUNGUS GROWTH; KERATOMYCOSIS; MALE; MINIMUM INHIBITORY CONCENTRATION; MONOTHERAPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; BAGG ALBINO MOUSE; CORNEA ULCER; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; FUNGAL EYE INFECTION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PROSPECTIVE STUDY;

AMPHOTERICIN B; ANIMALS; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; BIGUANIDES; CALCINEURIN; CORNEAL ULCER; CYCLOSPORINE; DISINFECTANTS; DRUG SYNERGISM; EYE INFECTIONS, FUNGAL; IMMUNOSUPPRESSIVE AGENTS; MALE; MICE; MICE, INBRED BALB C; MICROBIAL SENSITIVITY TESTS; PROSPECTIVE STUDIES; PYRIMIDINES; TACROLIMUS; TRIAZOLES;

EID: 84856394698     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.11-7739     Document Type: Article

References (35)

1. Klotz SA, Penn CC, Negvesky GJ, Butrus SI. Fungal and parasitic infections of the eye. Clin Microbiol Rev. 2000;13:662-685.
2. Thomas PA. Current perspectives on ophthalmic mycoses. Clin Microbiol Rev. 2003;16:730-797.
3. Basak SK, Basak S, Mohanta A, Bhowmick A. Epidemiological and microbiological diagnosis of suppurative keratitis in Gangetic West Bengal, eastern India. Indian J Ophthalmol. 2005;53:17-22.
4. Bharathi MJ, Ramakrishnan R, Vasu S, Palaniappan R. Aetiological diagnosis of microbial keratitis in South India: a study of 1618 cases. Indian J Med Microbiol. 2002;20:19-24.
5. Hagan M, Wright E, Newman M, Dolin P, Johnson G. Causes of suppurative keratitis in Ghana. Br J Ophthalmol. 1995;79:1024-1028.
6. Leck AK, Thomas PA, Hagan M, et al. Aetiology of suppurative corneal ulcers in Ghana and south India, and epidemiology of fungal keratitis. Br J Ophthalmol. 2002;86:1211-1215.
7. Srinivasan M. Fungal keratitis. Curr Opin Ophthalmol. 2004;15: 321-327.
8. Thomas PA. Fungal infections of the cornea. Eye (Lond). 2003;17: 852-862.
9. Gallis HA, Drew RH, Pickard WW. Amphotericin B: 30 years of clinical experience. Rev Infect Dis. 1990;12:308-329.
10. Hariprasad SM, Mieler WF, Lin TK, Sponsel WE, Graybill JR. Voriconazole in the treatment of fungal eye infections: a review of current literature. Br J Ophthalmol. 2008;92:871-878.
11. Wood TO, Tuberville AW, Monnett R. Keratomycosis and amphotericin B. Trans Am Ophthalmol Soc. 1985;83:397-409.
12. Kaur IP, Rana C, Singh H. Development of effective ocular preparations of antifungal agents. J Ocul Pharmacol Ther. 2008;24: 481-493.
13. Mehta H, Mehta HB, Garg P, Kodial H. Voriconazole for the treatment of refractory Aspergillus fumigatus keratitis. Indian J Ophthalmol. 2008;56:243-245.
14. Jones A, Muhtaseb M. Use of voriconazole in fungal keratitis. J Cataract Refract Surg. 2008;34:183-184.
15. Jhanji V, Sharma N, Mannan R, Titiyal JS, Vajpayee RB. Management of tunnel fungal infection with voriconazole. J Cataract Refract Surg. 2007;33:915-917.
16. Snelders E, van der Lee HA, Kuijpers J, et al. Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism. PLoS Med. 2008;5:e219.
17. Bellete B, Raberin H, Morel J, Flori P, Hafid J, Manhsung RT. Acquired resistance to voriconazole and itraconazole in a patient with pulmonary aspergilloma. Med Mycol. 2010;48:197-200.
18. Beernaert LA, Pasmans F, Van Waeyenberghe L, et al. Avian Aspergillus fumigatus strains resistant to both itraconazole and voriconazole. Antimicrob Agents Chemother. 2009;53:2199-2201.
19. Messick CR, Pendland SL, Moshirfar M, et al. In-vitro activity of polyhexamethylene biguanide (PHMB) against fungal isolates associated with infective keratitis. J Antimicrob Chemother. 1999;44: 297-298.
20. Fiscella RG, Moshifar M, Messick CR, Pendland SL, Chandler JW, Viana M. Polyhexamethylene biguanide (PHMB) in the treatment of experimental Fusarium keratomycosis. Cornea. 1997;16:447-449.
21. Panda A, Ahuja R, Biswas NR, Satpathy G, Khokhar S. Role of 0.02% polyhexamethylene biguanide and 1% povidone iodine in experimental Aspergillus keratitis. Cornea. 2003;22:138-141.
22. Clipstone NA, Crabtree GR. Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation. Nature. 1992;357: 695-697.
23. Fortwendel JR, Juvvadi PR, Pinchai N, et al. Differential effects of inhibiting chitin and 1,3-{beta}-D-glucan synthesis in ras and calcineurin mutants of Aspergillus fumigatus. Antimicrob Agents Chemother. 2009;53:476-482.
24. Steinbach WJ, Schell WA, Blankenship JR, Onyewu C, Heitman J, Perfect JR. In vitro interactions between antifungals and immunosuppressants against Aspergillus fumigatus. Antimicrob Agents Chemother. 2004;48:1664-1669.
25. Steinbach WJ, Cramer RA Jr, Perfect BZ, et al. Calcineurin controls growth, morphology, and pathogenicity in Aspergillus fumigatus. Eukaryot Cell. 2006;5:1091-1103.
26. Pinchai N, Perfect BZ, Juvvadi PR, et al. Aspergillus fumigatus calcipressin CbpA is involved in hyphal growth and calcium homeostasis. Eukaryot Cell. 2009;8:511-519.
27. Onyewu C, Afshari NA, Heitman J. Calcineurin promotes infection of the cornea by Candida albicans and can be targeted to enhance fluconazole therapy. Antimicrob Agents Chemother. 2006;50: 3963-3965.
28. Kontoyiannis DP, Lewis RE, Osherov N, Albert ND, May GS. Combination of caspofungin with inhibitors of the calcineurin pathway attenuates growth in vitro in Aspergillus species. J Antimicrob Chemother. 2003;51:313-316.
29. Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; approved standard. Document M38-A. Clinical and Laboratory Standards Institute, Wayne, PA; 2002.
30. Afeltra J, Dannaoui E, Meis JF, Rodriguez-Tudela JL, Verweij PE. In vitro synergistic interaction between amphotericin B and pentamidine against Scedosporium prolificans. Antimicrob Agents Chemother. 2002;46:3323-3326.
31. Steinbach WJ, Reedy JL, Cramer RA Jr, Perfect JR, Heitman J. Harnessing calcineurin as a novel anti-infective agent against invasive fungal infections. Nat Rev Microbiol. 2007;5:418-430.
32. Garcia ML, Herreras JM, Dios E, Argueso P, Almaraz A. Evaluation of lectin staining in the diagnosis of fungal keratitis in an experimental rabbit model. Mol Vis. 2002;8:10-16.
33. Dong X, Shi W, Zeng Q, Xie L. Roles of adherence and matrix metalloproteinases in growth patterns of fungal pathogens in cornea. Curr Eye Res. 2005;30:613-620.
34. Zhong W, Yin H, Xie L. Expression and potential role of major inflammatory cytokines in experimental keratomycosis. Mol Vis. 2009;15:1303-1311.
35. Haddad EM, McAlister VC, Renouf E, Malthaner R, Kjaer MS, Gluud LL. Cyclosporin versus tacrolimus for liver transplanted patients. Cochrane Database Syst Rev. 2006:CD005161.